An international team led by scientists at the University of Cologne recently reported the discovery of a human monoclonal antibody, designated 04_A06, that neutralizes almost all tested HIV-1 variants in vitro and retains activity against established escape mutations of the virus. The study brings together large-scale single-cell B-cell profiling, laboratory neutralization tests, structural biology analysis, … Novel Broadly Neutralizing Antibody Shows Near-Universal In Vitro Activity Against HIV-1 Read More » To access this post, you must purchase Individual Subscriber Yearly or Enterprise Subscriber.